Origin of symptoms in diverticular disease

British Journal of Surgery

Volumn 90, Issue 8, 2003, Pages 899-908

  Simpson, J ^a   Scholefield, J H ^a   Spiller, R C ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; COLON DIVERTICULOSIS; CONSULTATION; DIVERTICULOSIS; HUMAN; INFLAMMATION; INTESTINE PRESSURE; RECURRENT DISEASE; REVIEW; SYMPTOMATOLOGY; VISCERAL PAIN; COLITIS; IRRITABLE COLON; VISCERA;

ABDOMINAL PAIN; COLITIS; COLONIC DISEASES, FUNCTIONAL; DIVERTICULUM, COLON; HUMANS; VISCERA;

EID: 0042420454     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4277     Document Type: Review

References (127)

1. Parks TG. Natural history, of diverticular disease of the colon. Clin Gastroenterol 1975; 4: 53-69.
2. Cortesini C, Pantalone D. Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease. Dis Colon Rectum 1991; 34: 339-342.
3. Almy TP, Howell DA. Medical progress. Diverticular disease of the colon. N Engl J Med 1980; 302: 324-331.
4. Zollinger RW. The prognosis in diverticulitis of the colon. Arch Surg 1968; 97: 418-422.
5. Simpson J, Neal KR, Scholefield JH, Spiller RC. Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol 2003 (in press).
6. Simpson J, Spiller RC. Colonic diverticular disease. Clin Evid 2002; 7: 398-405.
7. Painter NS, Truelove SC, Ardran GM, Tuckey M. Segmentation and the localization of intraluminal pressures in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology 1965; 49: 169-177.
8. Simpson J, Scholefield JH, Spiller RC. Pathogenesis of colonic diverticula. Br J Surg 2002; 89: 546-554.
9. Eastwood MA, Smith AN, Brydon WG, Pritchard J. Colonic function in patients with diverticular disease. Lancet 1978; i: 1181-1182.
10. Eastwood MA, Watters DA, Smith AN. Diverticular disease - is it a motility disorder? Clin Gastroenterol 1982; 11: 545-561.
11. Weinreich J, Andersen D. Intraluminal pressure in the sigmoid colon. IL Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 1976; 11: 581-586.
12. Arfwidsson S. Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chirurg Scand Suppl 1964; 342: 1-68.
13. Painter NS. The cause of diverticular disease of the colon, its symptoms and its complications. Review and hypothesis. J R Coll Surg Edinb 1985; 30: 118-122.
14. Morson BC. Pathology of diverticular disease of the colon. Clin Gastroenterol 1975; 4: 37-52.
15. Connell AM. Applied physiology of the colon: factors relevant to diverticular disease. Clin Gastroenterol 1975; 4: 23-36.
16. Parks TG, Connell AM. Motility studies in diverticular disease of the colon. Gut 1969; 10: 534-542.
17. Flynn M, Hyland J, Hammond P, Darby C, Taylor I. Faecal bile acid excretion in diverticular disease. Br J Surg 1980; 67: 629-632.
18. Hyland JM, Darby CF, Hammond P, Taylor I. Myoelectrical activity of the sigmoid colon in patients with diverticular disease and the irritable colon syndrome suffering from diarrhoea. Digestion 1980; 20: 293-299.
19. Taylor I, Duthie HL. Bran tablets and diverticular disease. BMJ 1976; i: 988-990.
20. Huizinga JD, Waterfall WE, Stern HS. Abnormal myogenic control activity in colonic smooth muscle from diverticular disease patients. Proceeding of the Smooth Muscle Function Symposium, Banff, 1986.
21. Huizinga JD, Waterfall WE, Stern HS. Abnormal response to cholinergic stimulation in the circular muscle layer of the human colon in diverticular disease. Scand J Gastroenterol 1999; 34: 683-688.
22. Gold MH Jr, Carlson GM, Mathias JR. Colonic myoelectrical activity in diverticulosis. Gastroenterology 1979; 76: 1139 (Abstract).
23. Parks TG. Rectal and colonic studies after resection of the sigmoid for diverticular disease. Gut 1970; 11: 121-125.
24. Reilly M. Sigmoid myotomy. Br J Surg 1966; 53: 859-863.
25. Attisha RP, Smith AN. Pressure activity of the colon and rectum in diverticular disease before and after sigmoid myotomy. Br J Surg 1969; 56: 891-894.
26. Smith AN. Colonic muscle in diverticular disease. Clin Gastroenterol 1986; 15: 917-935.
27. Painter NS. Irritable or irritated bowel BMJ 1972; ii: 46 (Letter).
28. Findlay JM, Smith AN, Mitchell WD, Anderson AJ, Eastwood MA. Effects of unprocessed bran on colon function in normal subjects and in diverticular disease. Lancet 1974; i: 146-149.
29. Brodribb AJ, Humphreys DM. Diverticular disease: three studies. Part II - treatment with bran. BMJ 1976; i: 425-428.
30. Eastwood MA, Smith AN, Brydon WG, Pritchard J. Comparison of bran, ispaghula, and lactulose on colon function in diverticular disease. Gut 1978; 19: 1144-1147.
31. Srivastava GS, Smith AN, Painter NS. Stercuha bulk-forming agent with smooth-muscle relaxant versus bran in diverticular disease. BMJ 1976; i: 315-318.
32. Kirwan WO, Smith AN, Colonic propulsion in diverticular disease, idiopathic constipation, and the irritable colon syndrome. Scand J Gastroenterol 1977; 12: 331-335.
33. Manousos ON, Truelove SC, Lumsden K. Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. BMJ 1967; iii: 760-762.
34. Painter NS. Diverticulosis of the colon - fact and speculation. AmJ Dig Dis 1967; 12: 222-227.
35. Painter NS. The aetiology of diverticulosis of the colon with special reference to the action of certain drugs on the behaviour of the colon. Ann R Coll Surg Engl 1964; 34: 98-119.
36. Wyman JB, Heaton KW, Manning AP, Wicks AC. Variability of colonic function in healthy subjects. Gut 1978; 19: 146-150.
37. Conclusions of the 'Motility Group'. Classification and interpretation of motility records. Am J Dig Dis 1965; 10: 481-483.
38. Hodgson WJ. The placebo effect. Is it important in diverticular disease? Am J Gastroenterol 1977; 67: 157-162.
39. Flynn M, Darby C, Hyland J, Hammond P, Taylor I. The effect of bile acids on colonic myoelectrical activity. Br J Surg 1979; 66: 776-779.
40. Painter NS, Burkitt DP. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 1975; 4: 3-21.
41. Tarpila S, Miettinen TA, Metsaranta L. Effects of bran on serum cholesterol, faecal mass, fat, bile acids and neutral sterols, and biliary lipids in patients with diverticular disease of the colon. Gut 1978; 19: 137-145.
42. Antonis A, Bersohn I. The influence of diet on faecal lipids in South African white and Bantu prisoners. Am J Clin Nutr 1962; 11: 142-155.
43. Eastwood MA, Smith AN, Mitchell WD, Pritchard JL. Faecal characteristics and colonic intraluminal pressure in diverticular disease. Digestion 1980; 20: 399-402.
44. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995; 9: 33-39.
45. Hughes LE. Postmortem survey of diverticular disease of the colon. II. The muscular abnormality of the sigmoid colon. Gut 1969; 10: 344-351.
46. Shepherd NA. Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 1996; 38: 801-802.
47. Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996; 20: 94-102.
48. Gledhill A, Dixon MF. Crohn's-like reaction in diverticular disease. Gut 1998; 42: 392-395.
49. Gore S, Shepherd NA, Wilkinson SP. Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis 1992; 7: 76-81.
50. Sladen GE, Filipe MI. Is segmental colitis a complication of diverticular disease? Dis Colon Rectum 1984; 27: 513-514.
51. Shepherd NA. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 1991; 44: 726-733.
52. Petros JG, Happ RA. Crohn's colitis in patients with diverticular disease. Am J Gastroenterol 1991; 86: 247-248.
53. Peppercorn MA. Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 1992; 87: 609-612.
54. Goldstein NS, Leon-Armin C, Mani A. Crohn's colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn's colitis. Am J Surg Pathol 2000; 24: 668-675.
55. Imperiali G, Meucci G, Alvisi C, Fasoli R, Ferrara A, Girelli CM et al. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Inflammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 1014-1016.
56. Stein R, Hart J, Hanauer S. Segmental colitis limited to the sigmoid colon: can we predict the clinical course based upon endoscopic and histologic findings? A long-term follow up study. Gastroenterology 1998; 114: A1090-1091 (Abstract).
57. Horgan AF, McConnell EJ, Wolff BG, The S, Paterson C. Atypical diverticular disease: surgical results. Dis Colon Rectum 2001; 44: 1315-1318.
58. Moreaux J, Vons C. Elective resection for diverticular disease of the sigmoid colon. Br J Surg 1990; 77: 1036-1038.
59. Fleischner FG. Diverticular disease of the colon. New observations and revised concepts. Gastroenterology 1971; 60: 316-324.
60. Goldstein NS, Ahmad E. Histology of the mucosa in sigmoid colon specimens with diverticular disease: observations for the interpretation of sigmoid colonoscopic biopsy specimens. Am J Clin Pathol 1997; 107: 438-444.
61. Morson BC. The muscular abnormality in diverticular disease of the colon. Proc R Soc Med 1963; 56: 798-800.
62. Munson KD, Hensien MA, Jacob LN, Robinson AM, Liston WA. Diverticulitis. A comprehensive follow-up. Dis Colon Rectum 1996; 39: 318-322.
63. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-782.
64. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983; 24: 190-192.
65. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut 1999; 45(Suppl 2): II6-II16.
66. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999; 45(Suppl 2): II17-II24.
67. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-293.
68. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
69. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 1991; 36: 1249-1254.
70. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845-852.
71. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2): II37-II42.
72. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 2002; 51(Suppl 1): I67-I71.
73. Tracey DJ, Walker JS. Pain due to nerve damage: are inflammatory, mediators involved? Inflamm Res 1995; 44: 407-411.
74. Kennedy C, Leff P. Painful connection for ATP. Nature 1995; 377: 385-386.
75. Purcell WM, Atterwill CK. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem Res 1995; 20: 521-532.
76. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997; 112: 1714-1743.
77. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 2000; 278: G834-G838.
78. Kirkup AJ, Brunsden AM, Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 2001; 280: G787-G794.
79. McLean PG, Picard C, Garcia-Villar R, More J, Fioramonti J, Bueno L. Effects of nematode infection on sensitivity to intestinal distension: role of tachykinin NK2 receptors. Eur J Pharmacol 1997; 337: 279-282.
80. De Giorgio R, Stanghellini V, Barbara G, Corinaldesi R, De Ponti F, Tonini M et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gasrroenterol 2000; 35: 114-122.
81. De Giorgio R, Barbara G, Stanghellini V, Cogliandro RF, Arrigoni A, Santini D et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 2000; 12: 613-616.
82. Smith VV, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 1366-1371.
83. Tornblom H, Lindberg G, Nyberg B, Veress B. Histopathological findings in the jejunum of patients with severe irritable bowel syndrome. Gastroenterology 2000; 118: A140 (Abstract).
84. Dvorak AM, Silen W. Differentiation between Crohn's disease and other inflammatory conditions by electron microscopy. Ann Surg 1985; 201: 53-63.
85. Dvorak AM, Osage JE, Monahan RA, Dickersin GR. Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980; 11: 620-634.
86. Sharkey KA, Coggins PJ, Tetzlaff W, Zwiers H, Bisby MA, Davision JS. Distribution of growth-associated protein, B-50 (GAP-43) in the mammalian enteric nervous system. Neuroscience 1990; 38: 13-20.
87. Bueno L, Fioramonti J. Visceral perception: inflammatory and non-inflammatory mediators. Gut 2002; 51(1): i19-i23.
88. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-1699.
89. Collins SM. Irritable bowel could be an inflammatory disorder. Eur J Gastroenterol Hepatol 1994; 6: 478-482.
90. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Wakers SJ et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-406.
91. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811.
92. Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Muller-Lissner S et al. Potential pitfalls in the differential diagnosis of irritable bowel syndrome. Digestion 2000; 61: 247-256.
93. Barbara G, Corinaldesi R. Probiotics: could they turn out to be ineffective in irritable bowel syndrome? Dig Liver Dis 2000; 32: 302-304.
94. Chan J, Gonsalkorale WM, Perrey C, Previca V, Hajeer AH, Whorwell PJ et al. IL-10 and TGF-B genotypes in irritable bowel syndrome: evidence to support an inflammatory component? Gastroenterology 2000; 118: A184 (Abstract).
95. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 1224-1232.
96. Mao Y, Wang L, Chen Y, Blennerhassett P, Collins SM, Tougas G. Hyperalgesic colonic sensory afferent pathways following T. spiralis enteritis: involvement of NK1 receptors. Gastroenterology 2000; 118: AT01 (Abstract).
97. Jacobson K, McHugh K, Collins SM. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995; 109: 718-722.
98. Whiteway J, Morson BC. Elastosis in diverticular disease of the sigmoid colon. Gut 1985; 26: 258-266.
99. Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol 1999; 155: 1051-1057.
100. Simpson J, Haji-Suyoi A, Jenkins D, Scholefield JH, Spiller RC. Quantification of neurological changes in resection specimens with complicated and uncomplicated diverticular disease. Gastroenterology 2002; 122: A314 (Abstract).
101. Stead RH. Nerve remodelling during intestinal inflammation. Ann N Y Acad Sci 1992; 664: 443-455.
102. Brewer DB, Thompson H, Haynes IG, Alexander-Williams J. Axonal damage in Crohn's disease is frequent, but non-specitic. J Pathol 1990; 161: 301-311.
103. Karanth SS, Dhital S, Springall DR, Polak JM. Reinnervation and neuropeptides in mouse skin flaps. J Auton Nerv Syst 1990; 31: 127-134.
104. Kishimoto S. The regeneration of substance P-containing nerve fibers in the process of burn wound healing in the guinea pig skin. J Invest Dermatol 1984; 83: 219-223.
105. Di Sebastiano P, Fink T, di Mola FF, Weihe E, Innocenti P, Friess H et al. Neuroimmune appendicitis. Lancet 1999; 354: 461-466.
106. Bouchard S, Russo P, Radu AP, Adzick NS. Expression of neuropeptides in normal and abnormal appendices. J Pediatr Surg 2001; 36: 1222-1226.
107. Milner P, Crowe R, Kamm MA, Lennard-Jones JE, Burnstock G. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 1990; 99: 666-675.
108. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000; 47(Suppl 2): ii1-ii19.
109. Otte JJ, Larsen L, Andersen JR. Irritable bowel syndrome and symptomatic diverticular disease - different diseases? Am J Gastroenterol 1986; 81: 529-531.
110. Thompson WG, Patel DG, Tao H, Nair RC. Does uncomplicated diverticular disease produce symptoms? Dig Dis Sci 1982; 27: 605-608.
111. Sim GP, Scobie BA. Large bowel diseases in New Zealand based on 1118 air contrast enemas. N Z Med J 1982; 95: 611-613.
112. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. BMJ 1978; ii: 653-654.
113. Lumsden K, Chaudhary NA, Truelove SC. The irritable colon syndrome. Clin Radiol 1963; 14: 54-63.
114. Segal I, Walker AR. The irritable bowel syndrome in the black community. S Afr Med J 1984; 65: 72-73.
115. Painter NS, Burkitt DP. Diverticular disease of the colon: a deficiency disease of Western civilization. BMJ 1971; ii: 450-454.
116. Horner JL. Natural history of diverticulosis of the colon. Am J Dig Dis 1958; 3: 343-350.
117. Havia T, Manner R. The irritable colon syndrome. A follow-up study with special reference to the development of diverticula. Acta Chirurg Scand 1971; 137: 569-572.
118. Parks TG. Natural history of diverticular disease of the colon. A review of 521 cases. BMJ 1969; iv: 639-642.
119. Katschinski M, Lederer P, Ellermann A, Ganzleben R, Lux G, Arnold R. Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis. Scand J Gastroenterol 1990; 25: 761-768.
120. Trotman IF, Misiewicz JJ. Sigmoid motility in diverticular disease and the irritable bowel syndrome. Gut 1988; 29: 218-222.
121. Suchowiecky M, Clarke DD, Bhasker M, Perry RJ, Snape WJ Jr. Effect of secoverine on colonic myoelectric activity in diverticular disease of the colon. Dig Dis Sci 1987; 32: 833-840.
122. Snape WJ Jr, Carlson GM, Cohen S. Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology 1976; 70: 326-330.
123. Bose M, Farthing MJ. Irritable bowel syndrome: new horizons in pathophysiology and treatment. Br J Surg 2001; 88: 1425-1426.
124. Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-512.
125. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78-82.
126. Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63: 365-375.
127. Asfaha S, MacNaughton WK, Appleyard CB, Chadee K, Wallace JL. Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2001; 281: G635-G644.